Literature DB >> 21947008

Structural basis of RNA recognition and activation by innate immune receptor RIG-I.

Fuguo Jiang1, Anand Ramanathan, Matthew T Miller, Guo-Qing Tang, Michael Gale, Smita S Patel, Joseph Marcotrigiano.   

Abstract

Retinoic-acid-inducible gene-I (RIG-I; also known as DDX58) is a cytoplasmic pathogen recognition receptor that recognizes pathogen-associated molecular pattern (PAMP) motifs to differentiate between viral and cellular RNAs. RIG-I is activated by blunt-ended double-stranded (ds)RNA with or without a 5'-triphosphate (ppp), by single-stranded RNA marked by a 5'-ppp and by polyuridine sequences. Upon binding to such PAMP motifs, RIG-I initiates a signalling cascade that induces innate immune defences and inflammatory cytokines to establish an antiviral state. The RIG-I pathway is highly regulated and aberrant signalling leads to apoptosis, altered cell differentiation, inflammation, autoimmune diseases and cancer. The helicase and repressor domains (RD) of RIG-I recognize dsRNA and 5'-ppp RNA to activate the two amino-terminal caspase recruitment domains (CARDs) for signalling. Here, to understand the synergy between the helicase and the RD for RNA binding, and the contribution of ATP hydrolysis to RIG-I activation, we determined the structure of human RIG-I helicase-RD in complex with dsRNA and an ATP analogue. The helicase-RD organizes into a ring around dsRNA, capping one end, while contacting both strands using previously uncharacterized motifs to recognize dsRNA. Small-angle X-ray scattering, limited proteolysis and differential scanning fluorimetry indicate that RIG-I is in an extended and flexible conformation that compacts upon binding RNA. These results provide a detailed view of the role of helicase in dsRNA recognition, the synergy between the RD and the helicase for RNA binding and the organization of full-length RIG-I bound to dsRNA, and provide evidence of a conformational change upon RNA binding. The RIG-I helicase-RD structure is consistent with dsRNA translocation without unwinding and cooperative binding to RNA. The structure yields unprecedented insight into innate immunity and has a broader impact on other areas of biology, including RNA interference and DNA repair, which utilize homologous helicase domains within DICER and FANCM.
© 2011 Macmillan Publishers Limited. All rights reserved

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21947008      PMCID: PMC3430514          DOI: 10.1038/nature10537

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  38 in total

Review 1.  SF1 and SF2 helicases: family matters.

Authors:  Margaret E Fairman-Williams; Ulf-Peter Guenther; Eckhard Jankowsky
Journal:  Curr Opin Struct Biol       Date:  2010-04-22       Impact factor: 6.809

2.  Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses.

Authors:  Kiyohiro Takahasi; Mitsutoshi Yoneyama; Tatsuya Nishihori; Reiko Hirai; Hiroyuki Kumeta; Ryo Narita; Michael Gale; Fuyuhiko Inagaki; Takashi Fujita
Journal:  Mol Cell       Date:  2008-01-31       Impact factor: 17.970

3.  Three conformational snapshots of the hepatitis C virus NS3 helicase reveal a ratchet translocation mechanism.

Authors:  Meigang Gu; Charles M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-31       Impact factor: 11.205

4.  Viral apoptosis is induced by IRF-3-mediated activation of Bax.

Authors:  Saurabh Chattopadhyay; Joao T Marques; Michifumi Yamashita; Kristi L Peters; Kevin Smith; Avanti Desai; Bryan R G Williams; Ganes C Sen
Journal:  EMBO J       Date:  2010-04-01       Impact factor: 11.598

5.  The structural basis of 5' triphosphate double-stranded RNA recognition by RIG-I C-terminal domain.

Authors:  Cheng Lu; Hengyu Xu; C T Ranjith-Kumar; Monica T Brooks; Tim Y Hou; Fuqu Hu; Andrew B Herr; Roland K Strong; C Cheng Kao; Pingwei Li
Journal:  Structure       Date:  2010-07-15       Impact factor: 5.006

6.  PHENIX: a comprehensive Python-based system for macromolecular structure solution.

Authors:  Paul D Adams; Pavel V Afonine; Gábor Bunkóczi; Vincent B Chen; Ian W Davis; Nathaniel Echols; Jeffrey J Headd; Li-Wei Hung; Gary J Kapral; Ralf W Grosse-Kunstleve; Airlie J McCoy; Nigel W Moriarty; Robert Oeffner; Randy J Read; David C Richardson; Jane S Richardson; Thomas C Terwilliger; Peter H Zwart
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

7.  Nucleotide sequences and modifications that determine RIG-I/RNA binding and signaling activities.

Authors:  Dina Uzri; Lee Gehrke
Journal:  J Virol       Date:  2009-02-18       Impact factor: 5.103

8.  Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA.

Authors:  Takeshi Saito; David M Owen; Fuguo Jiang; Joseph Marcotrigiano; Michael Gale
Journal:  Nature       Date:  2008-06-11       Impact factor: 49.962

9.  Cytosolic viral sensor RIG-I is a 5'-triphosphate-dependent translocase on double-stranded RNA.

Authors:  Sua Myong; Sheng Cui; Peter V Cornish; Axel Kirchhofer; Michaela U Gack; Jae U Jung; Karl-Peter Hopfner; Taekjip Ha
Journal:  Science       Date:  2009-01-01       Impact factor: 47.728

10.  Structural and functional insights into 5'-ppp RNA pattern recognition by the innate immune receptor RIG-I.

Authors:  Yanli Wang; Janos Ludwig; Christine Schuberth; Marion Goldeck; Martin Schlee; Haitao Li; Stefan Juranek; Gang Sheng; Ronald Micura; Thomas Tuschl; Gunther Hartmann; Dinshaw J Patel
Journal:  Nat Struct Mol Biol       Date:  2010-06-27       Impact factor: 15.369

View more
  226 in total

1.  Structural insights into the activation of RIG-I, a nanosensor for viral RNAs.

Authors:  Qiu-Xing Jiang; Zhijian J Chen
Journal:  EMBO Rep       Date:  2011-12-23       Impact factor: 8.807

Review 2.  Highlights of the advances in basic immunology in 2011.

Authors:  Juan Liu; Shuxun Liu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2012-04-23       Impact factor: 11.530

3.  High-throughput biological small-angle X-ray scattering with a robotically loaded capillary cell.

Authors:  S S Nielsen; M Møller; R E Gillilan
Journal:  J Appl Crystallogr       Date:  2012-02-09       Impact factor: 3.304

4.  Structural Basis for a Novel Interaction between the NS1 Protein Derived from the 1918 Influenza Virus and RIG-I.

Authors:  Alexander S Jureka; Alex B Kleinpeter; Gabriel Cornilescu; Claudia C Cornilescu; Chad M Petit
Journal:  Structure       Date:  2015-09-10       Impact factor: 5.006

5.  A non-canonical role of the p97 complex in RIG-I antiviral signaling.

Authors:  Qian Hao; Shi Jiao; Zhubing Shi; Chuanchuan Li; Xia Meng; Zhen Zhang; Yanyan Wang; Xiaomin Song; Wenjia Wang; Rongguang Zhang; Yun Zhao; Catherine C L Wong; Zhaocai Zhou
Journal:  EMBO J       Date:  2015-10-15       Impact factor: 11.598

Review 6.  Innate antiviral immune signaling, viral evasion and modulation by HIV-1.

Authors:  Arjun Rustagi; Michael Gale
Journal:  J Mol Biol       Date:  2013-12-08       Impact factor: 5.469

7.  Structural Insights into mitochondrial antiviral signaling protein (MAVS)-tumor necrosis factor receptor-associated factor 6 (TRAF6) signaling.

Authors:  Zhubing Shi; Zhen Zhang; Zhenzhen Zhang; Yanyan Wang; Chuanchuan Li; Xin Wang; Feng He; Lina Sun; Shi Jiao; Weiyang Shi; Zhaocai Zhou
Journal:  J Biol Chem       Date:  2015-09-18       Impact factor: 5.157

8.  MDA5 assembles into a polar helical filament on dsRNA.

Authors:  Ian C Berke; Xiong Yu; Yorgo Modis; Edward H Egelman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

9.  RIG-I Uses an ATPase-Powered Translocation-Throttling Mechanism for Kinetic Proofreading of RNAs and Oligomerization.

Authors:  Swapnil C Devarkar; Brandon Schweibenz; Chen Wang; Joseph Marcotrigiano; Smita S Patel
Journal:  Mol Cell       Date:  2018-09-27       Impact factor: 17.970

10.  Homologous RIG-I-like helicase proteins direct RNAi-mediated antiviral immunity in C. elegans by distinct mechanisms.

Authors:  Xunyang Guo; Rui Zhang; Jeffrey Wang; Shou-Wei Ding; Rui Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.